Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CENTER FOR ERNÆRING OG TERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.3%   Bankruptcy risk   16.0% 5.9% 6.0% 3.8% 3.2% 4.1% 16.3% 13.9%   Credit score (0-100)   13 41 40 51 54 49 3 3   Credit rating   BB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   296 517 554 595 472 395 0.0 0.0   EBITDA   -52.1 125 136 195 185 85.6 0.0 0.0   EBIT   -59.4 120 129 188 182 82.3 0.0 0.0   Pre-tax profit (PTP)   -59.5 120.4 129.2 188.0 175.6 78.8 0.0 0.0   Net earnings   -46.7 93.8 99.2 146.5 136.4 61.3 0.0 0.0   Pre-tax profit without non-rec. items   -59.5 120 129 188 176 78.8 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   9.6 21.5 14.8 8.6 5.3 1.9 0.0 0.0   Shareholders equity total   -40.2 53.6 153 299 436 497 372 372   Interest-bearing liabilities   0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0   Balance sheet total (assets)   626 667 825 744 1,135 719 372 372   Net Debt   -426 -482 -638 -611 -1,013 -598 -372 -372     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   296 517 554 595 472 395 0.0 0.0   Gross profit growth   2.6% 74.5% 7.2% 7.4% -20.8% -16.2% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   626 667 825 744 1,135 719 372 372   Balance sheet change%   95.9% 6.5% 23.7% -9.8% 52.6% -36.7% -48.3% 0.0%   Added value   -59.4 120.4 129.3 188.4 181.7 82.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -15 7 -13 -12 -7 -7 -2 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -20.1% 23.3% 23.3% 31.6% 38.5% 20.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -12.1% 18.1% 17.3% 24.0% 19.3% 8.9% 0.0% 0.0%   ROI %   -1,838.5% 449.5% 118.7% 75.9% 47.2% 17.5% 0.0% 0.0%   ROE %   -14.8% 27.6% 96.1% 64.8% 37.1% 13.1% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   -6.3% 8.0% 20.3% 58.0% 75.3% 87.6% 100.0% 50.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   818.5% -384.8% -469.1% -314.0% -547.8% -698.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 180.6% 1,728.3% 1,006.3% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   0.8 0.9 1.1 3.4 7.2 9.6 0.0 0.0   Current Ratio   0.8 0.9 1.1 1.6 1.5 3.0 0.0 0.0   Cash and cash equivalent   426.3 481.9 638.0 611.2 1,013.8 598.5 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -118.0 -37.3 80.0 253.7 362.2 432.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 82 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 86 0 0   EBIT / employee   0 0 0 0 0 82 0 0   Net earnings / employee   0 0 0 0 0 61 0 0